Retinal vein occlusion (RVO)
Clinical trials for Retinal vein occlusion (RVO) explained in plain language.
Never miss a new study
Get alerted when new Retinal vein occlusion (RVO) trials appear
Sign up with your email to follow new studies for Retinal vein occlusion (RVO), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
High-Dose eye injection tested against stubborn diabetic swelling
Disease control CompletedResearchers at Tanta University are testing whether a high-dose version of the eye injection aflibercept (8 mg) can improve vision in people with diabetic macular edema or retinal vein occlusion that has not responded well to earlier anti-VEGF treatments. The study enrolls 60 adu…
Matched conditions: RETINAL VEIN OCCLUSION (RVO)
Early phase 1 • Sponsor: Tanta University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a new gel make eye injections less painful?
Symptom relief CompletedThis trial tests whether a new anesthetic gel, Iheezo, reduces discomfort during intravitreal injections compared to standard numbing drops. Fifty patients receiving injections in both eyes on the same day will have one eye treated with Iheezo and the other with standard anesthes…
Matched conditions: RETINAL VEIN OCCLUSION (RVO)
Phase 4 • Sponsor: Retina Consultants of Delmarva • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Eye injection burden varies by disease, study finds
Knowledge-focused CompletedThis study looked at how much of a burden patients feel from repeated anti-VEGF eye injections for three different eye diseases: wet age-related macular degeneration, retinal vein occlusion, and diabetic macular edema. Researchers surveyed 393 patients about their treatment burde…
Matched conditions: RETINAL VEIN OCCLUSION (RVO)
Sponsor: Hospital Hietzing • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC